Stocklytics Platform
Asset logo for symbol AXGN
AxoGen
AXGN76
$16.26arrow_drop_down5.43%-$0.93
High Growth
Asset logo for symbol AXGN
AXGN76

$16.26

arrow_drop_down5.43%
Key Stats
Open$17.09
Prev. Close$17.19
EPS-0.33
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range16.19
17.48
52 Week Range3.45
17.48
Ratios
EPS-0.33
Fundamentals
Payout Ratio-
Industry average yield2.90%
Last Dividend pay dateFeb 12, 2010
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

AXGN-
US Healthcare Sector-
US Market-
warning

AXGN / Market

AXGN lose to the US Market which returned 1.00% over the last twenty four hours.
warning

AXGN / Healthcare Sector

AXGN lose to the US Healthcare sector which returned 2.95% over the last twenty four hours.

AxoGen (AXGN) Statistics

AxoGen Inc (AXGN) is a leading medical technology company that specializes in the development and commercialization of innovative surgical solutions for peripheral nerve repair. The company's mission is to improve the lives of patients with peripheral nerve injuries by providing them with advanced treatment options that restore function and enhance quality of life. AxoGen's proprietary nerve repair products are designed to bridge the gap in damaged nerves and promote regeneration, facilitating the restoration of both sensory and motor function.
When it comes to evaluating the performance of AxoGen Inc, several key statistics are worth considering. Firstly, the valuation metrics provide insights into the company's current market value and potential for future growth. These metrics include the price-to-earnings ratio, price-to-sales ratio, price-to-book ratio, and price-to-cash flow ratio. By analyzing these metrics, investors can assess whether AxoGen's stock is overvalued or undervalued relative to its industry peers.
add AxoGen  to watchlist

Keep an eye on AxoGen

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the EPS of AxoGen (AXGN) stock?

The Earnings Per Share (EPS) for AxoGen (AXGN), calculated on a diluted basis, is -$0.33. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of AxoGen (AXGN) stock?

The operating margin for AxoGen (AXGN) is -0.65%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of AxoGen (AXGN) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of AxoGen (AXGN) is -$1.85M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How has AxoGen (AXGN) stock's performance compared to its sector and the market over the past year?

Over the past year, AxoGen (AXGN) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.34%, AxoGen has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 47.67%, it has fallen short of the market average. This comparison highlights AxoGen 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of AxoGen (AXGN) stock?

The PE ratio for AxoGen (AXGN) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

How much debt does AxoGen (AXGN) have?

AxoGen (AXGN) has a total debt of $71.31M. The net debt, which accounts for cash and cash equivalents against the total debt, is $50.2M.

Take Your Investments to a Whole New Level